Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Genentech's cancer restructure made 'for scientific reasons'
The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” according to executives.
James Waldron
Sep 10, 2024 5:56am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
Genentech is laying off 93 staffers in South San Francisco
Aug 28, 2024 10:40am
Genentech to close cancer immunology research department
Aug 16, 2024 11:08am
Relay loses interest in SHP2 inhibitor after Genentech leaves
Aug 7, 2024 6:00am
Genentech offers Sangamo $2B+ biobucks in neuro licensing deal
Aug 6, 2024 8:05am